<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Biomedical Journal</title>
<title_fa>مجله بیومدیکال ایران</title_fa>
<short_title>IBJ</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ibj.pasteur.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1028-852X</journal_id_issn>
<journal_id_issn_online>2008-823X</journal_id_issn_online>
<journal_id_pii>-</journal_id_pii>
<journal_id_doi>10.61882/ibj</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>-</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>-</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<volume>29</volume>
<number>5</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Genome-Scale Metabolic Modeling Identifies Synergistic Metabolites that Enhance 5-Fluorouracil Efficacy in Colon Cancer.</title>
	<subject_fa>Cancer Biology</subject_fa>
	<subject>Cancer Biology</subject>
	<content_type_fa>مقاله کامل</content_type_fa>
	<content_type>Full Length/Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;Background:&lt;/b&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;Colon cancer remains a leading cause of cancer-related mortality, with the efficacy of standard chemotherapy agents such as 5-FU limited by resistance and toxicity.&lt;/span&gt;&lt;/span&gt;&lt;strong&gt; &lt;/strong&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;This study aimed to identify metabolites that enhance 5-FU efficacy in CRC using GEM&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;Methods: &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;GEM was applied using the FVSEOF algorithm to identify metabolites that enhance the therapeutic efficacy of 5-FU in CRC. Context-specific metabolic models were constructed from TCGA data using the ftINIT algorithm. By simulating TS inhibition, we identified aspartate, lysine, and valine as candidate metabolites with altered uptake under constrained biomass production. Among them, lysine and valine are essential amino acids and were chosen for experimental validation using MTT assays and flow cytometry in HT-29 CRC cells and HU02 normal fibroblasts&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;.&lt;br&gt;
&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;Results:&lt;/b&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;Our approach identified aspartate, lysine, and valine as candidate synergistic metabolites. Experimental validation confirmed the strong synergy of lysine and valine with 5-FU in HT-29 cells, while showing significantly reduced effects in normal fibroblasts&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;. Mechanistic analysis suggested that these amino acids enhance nucleotide demand and metabolic activity, amplifying 5-FU-induced stress. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;b&gt;&lt;span style=&quot;line-height:115%&quot;&gt;Conclusion:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span calibri=&quot;&quot; style=&quot;font-family:&quot;&gt; &lt;span style=&quot;font-family:Times New Roman;&quot;&gt;This study demonstrates synergistic interventions and introduces amino acid co-supplementation as a potential strategy to improve CRC therapy with reduced toxicity.&lt;i&gt; &lt;/i&gt;To our knowledge, this is the first study to employ GEM for the systematic prediction of metabolites that synergize with 5-FU, aiming to improve therapeutic outcomes in CRC. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Colorectal neoplasms, Computational biology, Drug synergism, Fluorouracil, Metabolic Networks and Pathways</keyword>
	<start_page>321</start_page>
	<end_page>334</end_page>
	<web_url>http://ibj.pasteur.ac.ir/browse.php?a_code=A-10-1700-5&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Hasan</first_name>
	<middle_name></middle_name>
	<last_name>Rahimi-Tamandegani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hasan.rahimi68@gmail.com</email>
	<code></code>
	<orcid>0009-0004-1658-8563</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Drug Design and Bioinformatics Unit, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Sayed-Amir</first_name>
	<middle_name></middle_name>
	<last_name>Marashi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>marashie@gmail.com</email>
	<code></code>
	<orcid>0000-0001-9801-7449</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ghazaleh</first_name>
	<middle_name></middle_name>
	<last_name>Ghavami</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ghghavami@gmail.com</email>
	<code></code>
	<orcid>0000-0003-1251-7712</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Drug Design and Bioinformatics Unit, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mahya</first_name>
	<middle_name></middle_name>
	<last_name>Mehrmohamadi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mahya07@gmail.com</email>
	<code></code>
	<orcid>0000-0002-6681-0810</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Soroush</first_name>
	<middle_name></middle_name>
	<last_name>Sardari*</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ssardari@hotmail.com</email>
	<code></code>
	<orcid>0000-0003-2080-7402</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Drug Design and Bioinformatics Unit, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
